论文部分内容阅读
目的探索研究磺苄西林钠治疗呼吸道系统感染的具体效果,为临床应用寻求依据。方法 90例呼吸道系统感染患者随机分为研究组和对照组,各45例。研究组应用磺苄西林钠进行治疗,对照组应用呋苄西林钠进行治疗,将两组研究对象的临床疗效以及细菌清除情况进行对比分析。结果研究组痊愈率为80.00%,显著高于对照组的60.00%;研究组总有效率为97.78%,显著高于对照组的82.22%;研究组细菌清除率为84.21%,显著高于对照组的64.10%,上述组间差异均具有统计学意义(P<0.05)。两组不良反应发生率均为2.22%,差异无统计学意义(P>0.05)。结论应用磺苄西林钠对呼吸道系统感染患者进行治疗,效果好,细菌清除率高,有利于促进患者康复,具有较高的推广应用价值。
Objective To explore the specific effect of carbenicillin sodium in the treatment of respiratory tract infections and seek the basis for clinical application. Methods 90 patients with respiratory tract infection were randomly divided into study group and control group, 45 cases in each group. The study group was treated with benzyl amoxicillin sodium, the control group was treated with furosemide sodium, the clinical efficacy of the two groups of subjects and bacterial clearance were compared. Results The cure rate was 80.00% in the study group, significantly higher than that in the control group (60.00%). The total effective rate in the study group was 97.78%, significantly higher than that in the control group (82.22%). The bacterial clearance rate in the study group was 84.21% Of 64.10%, the differences between the above groups were statistically significant (P <0.05). Adverse reactions in both groups were 2.22%, the difference was not statistically significant (P> 0.05). Conclusion The application of carbenicillin sodium in patients with respiratory tract infection treatment, the effect is good, high bacterial clearance, is conducive to promoting patient rehabilitation, has a high value of popularization and application.